Company Overview of Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. provides development solutions and delivery technologies for drugs, biologics, and consumer health products. The company’s Development and Clinical Services segment offers manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also provides analytical chemical and cell-based testing and scientific services; respiratory products formulation and manufacturing; regulatory consulting; and bioanalytical testing for biologic products. Its Oral Technologies segment offers oral delivery technologies, including formulation, development, and manufacturing services for the oral dose forms comprising p...
14 Schoolhouse Road
Somerset, NJ 08873
Key Executives for Catalent Pharma Solutions, Inc.
Senior Vice President of Global Operations
Group President for Development & Clinical Services Segment and Chief Executive Officer for Development & Clinical Services Segment
President of Oral Technologies - Modified Release Technology
Compensation as of Fiscal Year 2014.
Catalent Pharma Solutions, Inc. Key Developments
Catalent Pharma Solutions Expands Handling and Manufacturing Capabilities at New Jersey Facility
Jan 30 15
Catalent Pharma Solutions has announced the expansion of potent handling and manufacturing capabilities at its Somerset, New Jersey facility. Catalent has completed the expansion of facility and engineering controls for its high potency tableting and OptiMelt Hot Melt Extrusion operations in Somerset to supplement existing potent capabilities in oral solid and Zydis Fast Dissolve manufacturing. The company is now investing in additional potent containment for large scale blending, fluid bed processing, and high shear granulation, which will come online throughout the first half of 2015. The expansion creates a manufacturing Center of Excellence for potent handling across Catalent's portfolio of oral solid manufacturing solutions, which includes hot melt extrusion, high-shear and wet granulation processing, solvent-based capability, extrusion/spheronization, fluid-bed processing, Wurster coating, and compression and encapsulation. The Somerset facility is capable of handling SafeBridge Category 3 and 4, with SafeBridge certification expected in July of 2015.
Catalent Pharma Solutions and Sanofi Collaborate to Develop ADCs Using SMARTag Technology
Jan 20 15
Catalent Pharma Solutions announced that it has entered into collaboration with Sanofi -Aventis Recherche & Developpement to implement Catalent's SMARTag technology in the development of next generation antibody-drug conjugates, or ADCs. Under the agreement, Catalent will develop site-specifically modified antibody conjugates using Sanofi's proprietary antibodies. Catalent's precision protein-chemical engineering approach will enable Sanofi to evaluate site selective payload conjugation in order to enhance ADC pharmacokinetics, efficacy and safety. The collaborative work will involve teams at Sanofi, and Catalent's facility, in Emeryville, CA, which was formerly headquarters to Redwood Bioscience Inc.
Catalent Pharma Solutions, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015
Dec 24 14
Catalent Pharma Solutions, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions